Filippo Acconcia

Filippo Acconcia

Sep 21, 2017

Group 6 Copy 36
0
    Please wait...

    About This Project

    70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing A New Treatment For Neurodegenerative Diseases

    1 in 3 people over the age of 65 will die with Alzheimer's disease or some other form of dementia. Current...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Rapid Detection of Tuberculosis -SCSU-New Haven iGEM

    The World Health Organization reports 9.6 million new Tuberculosis cases in 2014. As a global health issue...

    Campaign Ended